PINZI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 4.504
AS - Asia 2.936
EU - Europa 2.222
SA - Sud America 506
AF - Africa 73
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.247
Nazione #
US - Stati Uniti d'America 4.393
IT - Italia 935
SG - Singapore 918
CN - Cina 731
HK - Hong Kong 425
BR - Brasile 391
VN - Vietnam 368
GB - Regno Unito 335
SE - Svezia 256
DE - Germania 119
RU - Federazione Russa 106
FI - Finlandia 100
ID - Indonesia 97
KR - Corea 89
IN - India 70
FR - Francia 59
NL - Olanda 55
CA - Canada 47
AR - Argentina 41
MX - Messico 41
UA - Ucraina 40
BD - Bangladesh 38
TR - Turchia 38
LT - Lituania 35
BG - Bulgaria 34
ES - Italia 29
IQ - Iraq 26
JP - Giappone 22
BE - Belgio 21
PL - Polonia 21
EC - Ecuador 19
VE - Venezuela 18
ZA - Sudafrica 18
AT - Austria 17
CO - Colombia 17
IE - Irlanda 15
PK - Pakistan 14
AE - Emirati Arabi Uniti 12
IR - Iran 12
UZ - Uzbekistan 12
EG - Egitto 10
KE - Kenya 9
PH - Filippine 9
SA - Arabia Saudita 8
TN - Tunisia 8
CH - Svizzera 7
MA - Marocco 7
IL - Israele 6
JO - Giordania 6
UY - Uruguay 6
AZ - Azerbaigian 5
CL - Cile 5
GR - Grecia 5
RO - Romania 5
TT - Trinidad e Tobago 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
HR - Croazia 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NP - Nepal 4
SN - Senegal 4
AO - Angola 3
BB - Barbados 3
BY - Bielorussia 3
PE - Perù 3
PY - Paraguay 3
SI - Slovenia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DZ - Algeria 2
GE - Georgia 2
HN - Honduras 2
JM - Giamaica 2
KH - Cambogia 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
SC - Seychelles 2
TH - Thailandia 2
TW - Taiwan 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BH - Bahrain 1
BJ - Benin 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
Totale 10.233
Città #
Santa Clara 633
Ashburn 485
Singapore 479
Hong Kong 412
Fairfield 406
Chandler 288
Hefei 228
Nyköping 182
San Jose 180
Woodbridge 170
Modena 160
Beijing 140
Seattle 139
London 136
Houston 132
Ho Chi Minh City 130
Cambridge 120
Wilmington 112
Southend 109
Milan 97
Council Bluffs 94
Los Angeles 92
Bologna 91
Hanoi 91
Ann Arbor 88
Seoul 85
Helsinki 82
The Dalles 80
Jakarta 76
Chicago 75
New York 61
San Diego 44
Princeton 41
Dearborn 38
Reggio Emilia 36
Shanghai 36
São Paulo 35
Jacksonville 34
Sofia 32
Rome 31
Lauterbourg 30
Parma 30
Salt Lake City 28
Buffalo 27
Dallas 26
Munich 25
Orem 23
Moscow 21
Tampa 20
Brussels 19
Elk Grove Village 18
Tokyo 18
Toronto 17
Warsaw 17
Mexico City 16
Naples 16
Nuremberg 16
Chennai 15
Denver 15
Eugene 15
Haiphong 15
Kent 15
Poplar 15
Rio de Janeiro 15
Formigine 13
Mumbai 13
Redondo Beach 13
Izmir 12
Phoenix 12
Stockholm 12
Amsterdam 11
Biên Hòa 11
Da Nang 11
Frankfurt am Main 11
Lappeenranta 11
Vienna 11
Dublin 10
Guangzhou 10
Johannesburg 10
Kilburn 10
Montreal 10
Baghdad 9
Des Moines 9
Frattamaggiore 9
Nairobi 9
Tashkent 9
Turin 9
Atlanta 8
Bari 8
Boston 8
Brooklyn 8
Curitiba 8
Hải Dương 8
Meana Sardo 8
Paris 8
Redwood City 8
Boardman 7
Brasília 7
Brescia 7
Dhaka 7
Totale 6.797
Nome #
An unexpected reversal in the pharmacological stereoselectivity of benzothiadiazine AMPA positive allosteric modulators 361
Selection of protein conformations for structure-based polypharmacology studies 306
On the integration of in silico drug design methods for drug repurposing 304
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 291
Identification of small-molecule EGFR allosteric inhibitors by high-Throughput docking 278
Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space 274
Molecular docking: Shifting paradigms in drug discovery 273
Identification of Target Associations for Polypharmacology from Analysis of Crystallographic Ligands of the Protein Data Bank 273
Antifungal Activity and DNA Topoisomerase Inhibition of Hydrolysable Tannins from Punica granatum L. 266
Structure–Activity Relationships of Hexahydrocyclopenta[c]quinoline Derivatives as Allosteric Inhibitors of CDK2 and EGFR 263
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease 262
Identification of 4-aryl-1H-pyrrole[2,3-b]pyridine derivatives for the development of new B-Raf inhibitors 258
Prediction of activity and selectivity profiles of human Carbonic Anhydrase inhibitors using machine learning classification models 248
Evaluation of Amides, Carbamates, Sulfonamides, and Ureas of 4-Prop-2-ynylidenecycloalkylamine as Potent, Selective, and Bioavailable Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 245
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 243
Design of dual inhibitors of histone deacetylase 6 and heat shock protein 90 243
Computational polypharmacology comes of age 236
LigAdvisor: A versatile and user-friendly web-platform for drug design 221
Dual Targeting Strategies On Histone Deacetylase 6 (HDAC6) And Heat Shock Protein 90 (Hsp90) 216
2-Phenyloxazole-4-carboxamide as a Scaffold for Selective Inhibition of Human Monoamine Oxidase B 212
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 207
Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies 192
Chemoinformatics Analyses of Tau Ligands Reveal Key Molecular Requirements for the Identification of Potential Drug Candidates against Tauopathies 188
Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing 178
Refinement and rescoring of virtual screening results 178
Synthesis and biological evaluation of Hsp90/HDAC6 dual inhibitors bearing a 2-amino-pyrrolopyrimidine and purine scaffold as potential anticancer drugs to treat prostate cancer 176
How drug repurposing can advance drug discovery: challenges and opportunities 175
In silico repositioning of cannabigerol as a novel inhibitor of the enoyl acyl carrier protein (ACP) reductase (INHA) 171
Hydroxamic Acid Derivatives: From Synthetic Strategies to Medicinal Chemistry Applications 171
Virtual screening for dual Hsp90/B-Raf inhibitors 169
Repositioning natural products in drug discovery 166
Design, synthesis, biological evaluation and crystal structure determination of dual modulators of carbonic anhydrases and estrogen receptors 163
Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers 161
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring 161
Design and Synthesis of Hsp90 Inhibitors with B-Raf and PDHK1 Multi-Target Activity 160
Development of machine learning classifers to predict compound activity on prostate cancer cell lines. 158
Development and application of LigAdvisor, a user-friendly web-platform for polypharmacology and drug repurposing 151
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation 147
Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase 144
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B 136
On the development of B-Raf inhibitors acting through innovative mechanisms 131
Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR 128
Development of machine learning classifiers to predict compound activity on prostate cancer cell lines 127
Quantitative live cell imaging of a tauopathy model enables the identification of a polypharmacological drug candidate that restores physiological microtubule interaction 126
LigAdvisor: a web server to perform in silico explorations on crystallographic ligands and known drugs for polypharmacology and drug repurposing. 118
Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status 116
LigAdvisor: a web platform designed for charting novel polypharmacology and drug repurposing routes from crystallographic ligands and known drugs 111
Exploring Biological Targets of Magnolol and Honokiol and their Nature-Inspired Synthetic Derivatives: In Silico Identification and Experimental Validation of Estrogen Receptors 107
Targeting the allosteric sites of the B-Raf protein kinase through an in silico approach 106
Rational design of dual inhibitors of Hsp90 and B-Raf as a novel pharmacological approach against melanomas 104
Polypharmacology predictions in the Protein Data Bank 95
Unveiling target associations for polypharmacology from analysis of crystallographic ligands in the Protein Data Bank 95
Tackling polypharmacology and drug repurposing with the LigAdvisor webserver. 94
Trends and Applications in Computationally Driven Drug Repurposing 93
Rational design of dual inhibitors of Hsp90 and Braf as a novel pharmacological approach against melanomas 86
Predicting drug polypharmacology using structural databases 83
Totale 10.345
Categoria #
all - tutte 44.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.596


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021222 0 0 0 0 0 0 0 0 0 81 73 68
2021/2022807 67 41 48 52 19 36 49 61 88 54 192 100
2022/2023905 105 129 70 84 87 107 37 96 107 27 39 17
2023/2024793 29 44 54 79 138 61 102 111 17 14 49 95
2024/20252.554 64 19 67 188 490 314 134 185 220 286 264 323
2025/20263.705 296 188 355 560 602 215 508 190 428 363 0 0
Totale 10.345